A collaborative effort by a French medical device company (Bioserenity), a British epilepsy organization (Epilepsy Action), and a French epilepsy organization (Efappe) has led to the first of a kind smart clothing system and companion app that help monitor and diagnose epilepsy. Conventional epilepsy diagnosis and treatment rely on seizure recordings through fixed monitoring systems only available in a hospital setting. Due to the limited accessibility of these fixed systems, most often the patients’ seizures are not recorded. The lack of seizure information for a patient leads to suboptimal diagnosis and treatment. WEMU smartwear aims to improve the accuracy of diagnosis, reduce diagnostic time, and help design a more accurate drug regimen for the patient.